List view / Grid view
Having been available in Scotland and Northern Ireland since 2022,…
Having been available in Scotland and Northern Ireland since 2022, NICE’s positive opinion of the combination treatment means it is now accessible on the NHS.
Janssen states Imbruvica® plus venetoclax will provide "a much-needed new…
Janssen states Imbruvica® plus venetoclax will provide "a much-needed new treatment option" for chronic lymphocytic leukaemia.
NICE has released a Final Appraisal Document recommending Nexavar for…
NICE has released a Final Appraisal Document recommending Nexavar for the treatment of patients with advanced hepatocellular carcinoma...
Bayer have announced the European Commission has granted marketing authorisation…
Bayer have announced the European Commission has granted marketing authorisation for Stivarga...
